The AI in Healthcare Market is projected to reach $164.16 billion by 2030, with a CAGR of 49.1%. A recent survey found that 90% of healthcare executives are seeing positive returns on investment from generative AI initiatives.

Avant Technologies has partnered with Roche and Salud 360 to launch a pilot program in Costa Rica to combat diabetic retinopathy using AI technology. The program uses non-mydriatic fundus cameras and advanced AI algorithms to analyze retinal images for early detection of the condition. This is important in a country where diabetes affects 10.4% of adults.

If successful, the program may expand into the US, Canada, and European markets, demonstrating the increasing integration of AI solutions in healthcare to improve patient outcomes and operational efficiency.